P thor Straten - JoVE Visualize

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

Cancer Research|August 17, 2001

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patientsM H Andersen, L O Pedersen, B Capeller, et al.

Scandinavian Journal of Immunology|January 29, 2000

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.

Nucleic Acids Research|April 29, 1998

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresisP Guldberg, K Grønbak, A Aggerholm, et al.

Cancer Research|February 24, 2001

Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patientsD Schrama, M H Andersen, P Terheyden, et al.

Scandinavian Journal of Immunology|November 25, 2003

Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progressionP Terheyden, D Schrama, L Ø Pedersen, et al.

Immuno-Oncology Technology|April 24, 2025

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cellsM Velasco Santiago, P Aehnlich, T M Hulen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999

In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypesP thor Straten, P Guldberg, K Grønbaek, et al.

Immunity|March 10, 2001

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissueD Schrama, P thor Straten, W H Fischer, et al.

The British Journal of Dermatology|February 14, 2002

A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletionH Knudsen, K Grønbaek, P thor Straten, et al.

Clinical Immunology (Orlando, Fla.)|July 20, 2000

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro cultureP thor Straten, A F Kirkin, E Siim, et al.

Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

Cancer Research|August 17, 2001

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patientsM H Andersen, L O Pedersen, B Capeller, et al.

Scandinavian Journal of Immunology|January 29, 2000

Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.

Nucleic Acids Research|April 29, 1998

Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresisP Guldberg, K Grønbak, A Aggerholm, et al.

Cancer Research|February 24, 2001

Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patientsD Schrama, M H Andersen, P Terheyden, et al.

Scandinavian Journal of Immunology|November 25, 2003

Longitudinal analysis of MART-1/HLA-A2-reactive T cells over the course of melanoma progressionP Terheyden, D Schrama, L Ø Pedersen, et al.

Immuno-Oncology Technology|April 24, 2025

Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cellsM Velasco Santiago, P Aehnlich, T M Hulen, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999

In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypesP thor Straten, P Guldberg, K Grønbaek, et al.

Immunity|March 10, 2001

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissueD Schrama, P thor Straten, W H Fischer, et al.

The British Journal of Dermatology|February 14, 2002

A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletionH Knudsen, K Grønbaek, P thor Straten, et al.

Clinical Immunology (Orlando, Fla.)|July 20, 2000

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro cultureP thor Straten, A F Kirkin, E Siim, et al.

Pageof 4